Her main research concerns Receptor, G protein-coupled receptor, Signal transduction, G protein and Biochemistry. Evi Kostenis has included themes like Inflammation and Pharmacology in her Receptor study. Evi Kostenis has researched G protein-coupled receptor in several fields, including Cannabinoid receptor type 2, Enzyme-linked receptor, Angiotensin II, Angiotensin II receptor type 1 and Computational biology.
Her Signal transduction research incorporates themes from Cancer research and Immunology. Her research integrates issues of Protein structure and Arrestin in her study of G protein. Her Biochemistry study combines topics in areas such as Biophysics and Stereochemistry.
Receptor, G protein-coupled receptor, Cell biology, Signal transduction and Stereochemistry are her primary areas of study. Her Receptor study frequently involves adjacent topics like Pharmacology. Her study in Pharmacology is interdisciplinary in nature, drawing from both Prostaglandin and Prostaglandin D2.
Evi Kostenis works mostly in the field of G protein-coupled receptor, limiting it down to topics relating to Computational biology and, in certain cases, GPR55 and Cell signaling, as a part of the same area of interest. She combines subjects such as Chemotaxis and Immunology with her study of Signal transduction. Her Stereochemistry research is multidisciplinary, incorporating elements of Potency and Allosteric regulation.
Her primary areas of investigation include Cell biology, Receptor, G protein, Gq alpha subunit and Heterotrimeric G protein. Her work on Phosphorylation as part of general Cell biology research is frequently linked to Rational design, bridging the gap between disciplines. Her Receptor study frequently intersects with other fields, such as Endocrinology.
Evi Kostenis has researched G protein in several fields, including G protein-coupled receptor, Mutant, Transmembrane protein, HEK 293 cells and Second messenger system. Her studies in G protein-coupled receptor integrate themes in fields like Computational biology, Heterotrimeric G Protein Subunit and Endosome. Her Gq alpha subunit study is related to the wider topic of Signal transduction.
Evi Kostenis mainly investigates Cell biology, Gq alpha subunit, Heterotrimeric G protein, G protein and Signal transduction. Her Cell biology research incorporates elements of Agonist, Receptor, Glutamate receptor and Mechanism of action. Her Receptor research is multidisciplinary, relying on both Endocrinology and Pharmacology.
Her Gq alpha subunit research integrates issues from Cell signaling, Transmembrane protein, Mutagenesis, Structural similarity and Effector. Her work carried out in the field of Cell signaling brings together such families of science as Computational biology, G protein-coupled receptor, Membrane protein and Drug discovery. In general Signal transduction, her work in Focal adhesion, Hippo signaling pathway, Tyrosine phosphorylation and Hippo signaling is often linked to GNA11 linking many areas of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Heterotrimeric G-proteins: a short history
Graeme Milligan;Evi Kostenis.
British Journal of Pharmacology (2006)
G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor
Evi Kostenis;Graeme Milligan;Arthur Christopoulos;Carlos F. Sanchez-Ferrer.
Circulation (2005)
Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice
Jesus Gomeza;Harlan Shannon;Evi Kostenis;Christian Felder.
Proceedings of the National Academy of Sciences of the United States of America (1999)
A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers
Maria Waldhoer;Jamie Fong;Robert M. Jones;Mary M. Lunzer.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice
Jesus Gomeza;Lu Zhang;Evi Kostenis;Christian Felder.
Proceedings of the National Academy of Sciences of the United States of America (1999)
The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation
Christoph S.N. Klose;Tanel Mahlakõiv;Jesper B. Moeller;Jesper B. Moeller;Lucille C. Rankin.
Nature (2017)
Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements
Ralf Schröder;Nicole Janssen;Johannes Schmidt;Anna Kebig.
Nature Biotechnology (2010)
Identification of Nonpeptidic Urotensin II Receptor Antagonists by Virtual Screening Based on a Pharmacophore Model Derived from Structure−Activity Relationships and Nuclear Magnetic Resonance Studies on Urotensin II
Stefanie Flohr;Michael Kurz;Evi Kostenis;Alexandre Brkovich.
Journal of Medicinal Chemistry (2002)
Emerging roles of DP and CRTH2 in allergic inflammation
Evi Kostenis;Trond Ulven.
Trends in Molecular Medicine (2006)
The experimental power of FR900359 to study Gq-regulated biological processes
Ramona Schrage;Anna Lena Schmitz;Evelyn Gaffal;Suvi Annala.
Nature Communications (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Bonn
University of Copenhagen
University of Würzburg
University of Glasgow
University of Bonn
Tohoku University
University of Bonn
University of Bonn
University of Tokyo
Heinrich Heine University Düsseldorf
Stony Brook University
University of Pennsylvania
Stanford University
University of Missouri
Institute of Arctic and Alpine Research
University of Kentucky
University of Tennessee Health Science Center
University of Tsukuba
Royal Holloway University of London
University of Zurich
Lakehead University
National Center for Atmospheric Research
Brigham and Women's Hospital
University of California, San Francisco
University of Eastern Finland
University of Paris-Saclay